Warbritton John D MD is categorized under Orthopedic Doctors and Physicians in Oakland, CA and active since 1989.
Warbritton John D MD was established in 1989, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John Warbritton at the company’s single location by writing to 300 Frank H Ogawa Plaza # 700, Oakland, California CA 94612 or by phoning (510) 839-5564. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Warbritton John D MD |
Contact Person: | John Warbritton |
Address: | 300 Frank H Ogawa Plaza # 700, Oakland, California 94612 |
Phone Number: | (510) 839-5564 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1989 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Warbritton John D MD was started in 1989 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Warbritton for inquiries that concern Warbritton John D MD by calling the company number (510) 839-5564, as your correspondence is most welcome. Additionally, the physical location of the single location of Warbritton John D MD can be found at the coordinates 37.805266,-122.271494 as well as the street address 300 Frank H Ogawa Plaza # 700 in Oakland, California 94612.
For its online presence, you may visit Warbritton John D MD’s website at and engage with its social media outlets through on Twitter and on Facebook.